Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Soc Sci Med. 2020 Mar 19;253:112940. doi: 10.1016/j.socscimed.2020.112940

Table 3.

FIML Cross-lagged Regression Parameter Estimates.

Parameter Estimate SE Z p
Control Group
 Timepoint 2 Female Stigma ON
Timepoint 1 Female Stigma 0.56 0.10 5.67 < .001
Timepoint 1 Male Stigma 0.22 0.11 2.1 .036
 Timepoint 2 Male Stigma ON
Timepoint 1 Male Stigma 0.40 0.14 2.84 .004
Timepoint 1 Female Stigma 0.29 0.12 2.43 .015
 Covariance between Time 2 Male and Female Stigma 0.00 0.03 −0.09 .929
 Covariance between Time 1 Male and Female Stigma 0.11 0.03 3.74 < .001
 Means
Timepoint 1 Female Stigma 2.23 0.05 41.45 < .001
Timepoint 1 Male Stigma 2.19 0.05 43.07 < .001
 Intercepts
Timepoint 2 Female Stigma 0.50 0.24 2.12 .034
Timepoint 2 Male Stigma 0.64 0.30 2.18 .029
 Variances
Timepoint 1 Female Stigma 0.30 0.04 7.19 < .001
Timepoint 1 Male Stigma 0.25 0.04 6.96 < .001
 Residual Variances
Timepoint 2 Female Stigma 0.19 0.03 6.37 < .001
Timepoint 2 Male Stigma 0.17 0.04 4.82 < .001
Experimental Group
 Timepoint 2 Female Stigma ON
Timepoint 1 Female Stigma 0.37 0.16 2.36 .018
Timepoint 1 Male Stigma −0.12 0.12 −1.00 .319
 Timepoint 2 Male Stigma ON
Timepoint 1 Male Stigma 0.18 0.15 1.27 .205
Timepoint 1 Female Stigma 0.02 0.17 0.11 .911
 Covariance between Time 2 Male and Female Stigma 0.02 0.05 0.44 .66
 Covariance between Time 1 Male and Female Stigma 0.03 0.03 1.14 .253
 Means
Timepoint 1 Female Stigma 2.13 0.05 44.14 < .001
Timepoint 1 Male Stigma 2.19 0.06 37.98 < .001
 Intercepts
Timepoint 2 Female Stigma 1.61 0.39 4.09 < .001
Timepoint 2 Male Stigma 1.65 0.42 3.92 < .001
 Variances
Timepoint 1 Female Stigma 0.22 0.03 6.73 < .001
Timepoint 1 Male Stigma 0.31 0.05 6.85 < .001
 Residual Variances
Timepoint 2 Female Stigma 0.31 0.05 5.84 < .001
Timepoint 2 Male Stigma 0.26 0.06 4.62 < .001